insights_auto
Why is GEKA up 2.31%?
Dive Deeperchevron_right
GEKA:FRA
Genomma Lab Internacional SAB de CV
€0.66
arrow_upward
+2.31%(+0.015) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GEKA...
Open
€0.66
High
€0.66
Low
€0.66
Mkt. cap
14.43B
Avg. vol.
304.00
Volume
0.00
52-wk high
€0.95
52-wk low
€0.60
No. of employees
2K
Open
€0.66
High
€0.66
Low
€0.66
Mkt. cap
14.43B
Avg. vol.
304.00
Volume
0.00
52-wk high
€0.95
52-wk low
€0.60
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
6 hours ago
Genomma Lab stock: October 21 results are due for Genomma Lab stock
ad-hoc-news.de
·
12 hours ago
Genomma Lab brings back founder as CEO while Genomma Lab stock costs EUR 0.68
ad-hoc-news.de
·
1 day ago
Genomma Lab stock trades at EUR 0.68 as Investor Day nears
ad-hoc-news.de
·
2 days ago
Genomma Lab stock heads into the next Xetra session at EUR 0.68
Profile
Genomma Lab Internacional or simply Genomma Lab is a Mexican company, founded in 1996, dedicated to the commercialization of OTC medications and dermocosmetic products. It is part of the Índice de Precios y Cotizaciones, the main stock index of the Mexican Stock Exchange. It is one of the leading pharmaceutical companies in the country.
Genomma Lab Internacional, led by its owner Rodrigo Alonso Herrera Aspra, recorded net sales of 9,799.7 million Mexican pesos, equivalent to 756.0 million USD in 2012, achieving a 21.6% growth compared to 2011. Currently, Genomma Lab operates in 15 countries outside Mexico and has achieved success by replicating its business model. Wikipedia
About Genomma Lab Internacional SAB de CV
CEOJorge Luis Brake Valderrama
Employees1.66K
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitegenommalab.com